Sign in

Ancora.ai Clinical Trial Navigator

@ancoraai.bsky.social
56 followers 175 following 31 posts

Ancora.ai is an AI-enabled digital platform that enables cancer patients & their care teams to find trials. We believe technology can help improve access and make clinical trial navigation more efficient and effective. Check out the tool at www.ancora.ai

PostsRepliesMedia
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 29/09/2026
Lung NETs account for up to 20% of all lung cancers. Wheezing is one of the symptoms that can often mislead clinicians to think about common lung condition. ✅We support clinicians to detect lung NET early with #NETInfo in 14 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs
021 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 25/09/2026
Huge congrats to Dr. Andreas Hottinger on his oral presentation at #EANO2026! Dr. Hottinger presented on the #BrainTumor Trial Finder, a tool built by ancora.ai to help patients & providers navigate #clinicaltrials. For those at @eanoassociation.bsky.social come to the 5P booth to learn more!
011 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 24/09/2026
On #WorldCancerResearchDay, let’s praise all NET researchers whose dedication gives us advances in NET treatments. 📱Watch researchers’ insights to learn the latest in NEN research: incalliance.org/researcher-i... ✅Find NEN clinical trials worldwide: incalliance.org/find-a-trial/ #LetsTalkAboutNETs
012 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 22/09/2026
Attending #EANO26? Come join Dr. Andreas Hottinger at 18:00 on Sep. 24th at the Theatre Studio. Dr. Hottinger will present on the #braintumor trial finder and the impact we've made in 1 year. Link to tool - www.braintumortrialfinder.org Hope to see you there! #clinicaltrials #neurooncology
200 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 26/08/2026
Ancora.ai now includes all #cancer #clinicaltrials from the #EuropeanUnion Clinical Trial Information System! A huge thank you to everyone who supported our work. On www.ancora.ai you can search for cancer trials across 5 trial registries: ✔ Clinicaltrials.gov ✔ ISRCTN ✔ ANZCTR ✔ SAKK ✔ EU CTIS
000 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 26/05/2026
Great opportunity for #cancer #patient advocates in the California area to learn about #nuclearmedicine. @nucmed-patients.bsky.social is hosting a free Patient Education Day at #SNMMI2026 in LA in partnership w/ NCF. 📆 May 31 📍 LA Convention Center Link to Learn More: snmmi.org/Web/Educatio...
010 0
Reposted by Ancora.ai Clinical Trial Navigator
Alliance for Clinical Trials in Oncology @alliance-org.bsky.social · 25/05/2026
Now enrolling! Jennifer Ligibel MD of Dana-Farber’s Breast Oncology Center and Kathryn Schmitz PhD of UPMC Hillman lead Alliance A222302 studying the feasibility of a telehealth exercise program for cancer patients with the goal of reducing fatigue and disability. bit.ly/DEFEND-trial #NCI
021 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 26/05/2026
Hello! Firstly we want to say a huge thank you to everyone who helped share our fundraising request for #braintumor trial finding and to everyone who donated - we're so grateful! We're at $2,230 of our $7,000 target w/ only 23 days left & so we'd really appreciate any help sharing our fundraiser.
000 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 17/05/2026
We need your help! We launched a small #fundraiser to help fund the extension of our #patient- #clinicaltrial matching #AI tool for #braintumors. We'd be so grateful for any support to help us keep our work independent & free to patients. Link to learn more: experiment.com/projects/the...
000 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 07/05/2026
Looking for support! We just launched a small #fundraiser to help us fund the extension of our #AI patient- #clinicaltrial matching model for #braintumors. We'd be so grateful for any support and any help in spreading the word! Link to learn more- experiment.com/projects/the... Thank you!
experiment.com
The AI-powered brain tumor trial finder (BTTF) empowers patients and fosters innovation
Glioblastoma (GBM) is a devastating illness with a survival of <18 months; it touches people in the middle of their careers & lives. Guidelines list clinical trials as treatment of choice but o...
000 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 07/05/2026
Every NEN patient deserves access to clear information—no matter the language. Our #RadioligandTherapy guide is available in 15 languages to help patients feel informed and prepared. ⬇️ Free download: incalliance.org/net-info-pac... #LetsTalkAboutNETs
021 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 17/02/2026
Wonderful to see @braintumor.org launch their new #AI Clinical Trial Finder, proudly powered by @ancoraai.bsky.social #NBTS's Clinical Trial Finder tool helps match #braintumor patients to relevant #clinicaltrials in seconds. Explore this free resource to know your options: BrainTumor.org/Trials
braintumor.org
Clinical Trial Finder - National Brain Tumor Society
Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
010 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 10/12/2025
📌NEW VIDEO: Clinical trials related to #pheochromocytoma and #paraganglioma. 📱Watch Dr. Justin Annes presenting an overview of the specifics in diagnostics and treatment of #pheochromocytoma and #paraganglioma, and the ongoing clinical trials: incalliance.org/dr-justin-an... #LetsTalkAboutNETs
013 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 19/12/2025
As the year ends, we’re filled with gratitude 💫 Thank you to our patients for your trust in Ancora.ai 🙏 To our partners & sponsors: thank you for your collaboration & support in keeping the Ancora.ai Trial Finder tool free & accessible for all 👏 Wishing you all a peaceful holiday season!
000 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 09/12/2025
For the UK #neuroendocrinecancer community, please help Neuroendocrine Cancer UK with this survey: lnkd.in/efPpvrga By completing this survey, you will help shape the UK’s future neuroendocrine cancer research agenda & ensure that questions most important to patients, families & clinicians are heard
000 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 09/12/2025
📌The specifics of neuroendocrine carcinoma were discussed by NET experts and patients at the @enets.org & INCA NET Cancer Day 2025 Educational Webinar. 📱Now you can watch the recording at your own pace: incalliance.org/the-recordin... #LetsTalkAboutNETs
033 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 04/12/2025
📌The #ThinkNENs program is designed to empower PCPs with the knowledge to recognize NENs and refer NEN patients earlier. • Free, online & CME-accredited • Available in 7 languages • Endorsed by top NEN societies ✅Start today: incalliance.org/think-nens/ #LetsTalkAboutNETs
012 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 26/11/2025
💡 Just presented our abstract at the @netrf.org Medical Symposium 2025! Our data from the ancora.ai #NET Digital Trial Finder exposed a critical breakdown in patient recruitment. The issue? Patient interest is strong, but the follow-up process is failing them. #ClinicalTrials #NeuroEndocrineTumors
100 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 17/10/2025
Ancora.ai was honored to have attended the 1st-ever World #CUP Alliance meeting yesterday in Berlin! The meeting was an inspiring day full of incredible research & collaboration focused on improving the lives of patients with Cancer of Unknown Primary (CUP). #cancerunknownprimary
100 0
Reposted by Ancora.ai Clinical Trial Navigator
Dana-Farber News @danafarbernews.bsky.social · 22/09/2025
ICYMI: @danafarber.bsky.social's Patrick Wen, MD, spoke with @oncodaily.bsky.social On Air about the @fda.gov approval of Dordaviprone in H3K27M-mutated diffuse midline glioma. Listen here: bit.ly/3KqeLMk
bit.ly
FDA Approval Insights: Dordaviprone in H3K27M-Mutated Diffuse Midline Glioma: With Patrick Y. Wen, MD | OncLive
Dr Wen discussed the significance of the FDA approval of dordaviprone for patients at least 1 year of age with H3K27M-mutated diffuse midline glioma.
041 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 23/09/2025
Our #braintumor #clinicaltrial finder tool is now live! A huge thanks to our incredible expert group of #patient advocates, #physicians, researchers & #biotech as well as our collaborators 5P Health Care Solutions. Link to tool www.ancora.ai/braintumors Press release www.ancora.ai/en/newsartic...
110 0
Reposted by Ancora.ai Clinical Trial Navigator
International Neuroendocrine Cancer Alliance (INCA) @inca-netcancerday.bsky.social · 30/06/2025
Do you know how easy it is to quickly find a NEN clinical trial that fits your condition and is close to your location? ✅Try here: incalliance.org/find-a-trial/ #LetsTalkAboutNETs #NENClinicalTrials @ancoraai.bsky.social
011 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 23/05/2025
Our team was privileged to attend ICPO Foundation's forum- a fantastic gathering focused on the advancement of #radiopharmaceuticals in #oncology. We're grateful for the opportunity to have presented our newly released Global Radiopharmaceutical Trial Finder powered by Ancora.ai 💫 www.radtrials.com
120 0
Reposted by Ancora.ai Clinical Trial Navigator
Maximilian Mair @mj-mair.bsky.social · 24/02/2025
1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786
doi.org
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma - European Journal of Nuclear Medicine and Molecular Imaging
Purpose High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas...
162 0
Reposted by Ancora.ai Clinical Trial Navigator
Thor Halfdanarson @oncothor.bsky.social · 21/02/2025
Do you want to know what is happening in radioligand therapy for patients with neuroendocrine tumors? What is hot and what is not...? if so this team (which has not yet migrated over to BlueSky...) has you covered... 😀 onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
<em>Journal of Neuroendocrinology</em> | BSN Journal | Wiley Online Library
Neuroendocrine tumors encompass a wide range of tumors which originate from neural crest cells. These tumors were thought to be rare tumors, however, with the advent of advanced diagnostic techniques...
052 0
Reposted by Ancora.ai Clinical Trial Navigator
IASLC @iaslc.bsky.social · 28/02/2025
Patient advocate @sunonmyhip.bsky.social joins #LungCancerConsidered host @narjustflorezmd.bsky.social to discuss her lung cancer journey & the power of advocacy groups. Learn about self-advocacy, patient-centered care & palliative care. 🎧 Listen now: bit.ly/PAGroups #PatientAdvocacy
173 0
Reposted by Ancora.ai Clinical Trial Navigator
Yvonne Diaz @yvonnediaz.bsky.social · 05/03/2025
Professor @drjnaidoo.bsky.social welcomed to the #BTOG25 stage as a Lung Cancer Legend & doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards & future treatments. #LCSM
Photo of Dr Naidoo on stage Dr Naidoo presenting conclusionsCompares future to various movies
0187 0
Reposted by Ancora.ai Clinical Trial Navigator
Vall d’Hebron Institute of Oncology @vhio.bsky.social · 06/03/2025
Radioligand therapy demonstrates improved clinical benefit in patients with gastroenteropancreatic neuroendocrine tumors vs. molecular targeted therapy.  🔬 The results of #COMPETE trial were presented today by Jaume Capdevila, at the 22nd Annual Conference of #ENETS 👉 linke.to/COMPETEVHIO
042 0
Reposted by Ancora.ai Clinical Trial Navigator
Prostate Cancer Research @pcr-uk.bsky.social · 21/02/2025
David James spoke to Anna Jones at @skynewsrss.bsky.social this morning with patient advocate Dee to discuss why we need urgent reform in how we diagnose prostate cancer. Too many men are being diagnosed too late - we must act now. It's time for a screening programme www.youtube.com/watch?v=CdUB...
youtube.com
Sky News Interview
YouTube video by Prostate Cancer Research
052 0
Reposted by Ancora.ai Clinical Trial Navigator
SWOG Cancer Research Network @swog.org · 05/03/2025
The Winn Career Development Award is open for applications! The 2-year program provides training and support for early-stage investigator physicians to improve participation in clinical trials. Details at winnawards.org. Apply by May 12, 2025. #WinnAwards #WinnCDA @drdonsdizon.bsky.social
Winn Excellence in Clinical Trials Program
042 0
Reposted by Ancora.ai Clinical Trial Navigator
American Association for Cancer Research (AACR) @theaacr.bsky.social · 28/02/2025
Research-driven advances in cancer science have led to new treatments for the thousands of people diagnosed with rare cancers. Learn more on #RareDiseaseDay: cancerprogressreport.aacr.org/progress/cpr.... #CancerResearchSavesLives® #FundNIH
0124 0
Ancora.ai Clinical Trial Navigator @ancoraai.bsky.social · 04/03/2025
We're thrilled to announce the launch of the Brain Tumor Trial Finder project! We're embarking on a mission to expand the Ancora.ai #clinicaltrial finder to include brain tumors. Our goal is simple: make it easier for #braintumor patients to find & access clinical trials.
151 0